EPGNF — Stock Film
STOCK FILMSCENE 1/10EPGNF · $1.12
Stock Expert AI presents
EPGNF
Epigenomics AG
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Epigenomics AG. A quick introduction.

On the stock market since 2010, it operates in the world of health and science. It has 3 employees. Now — the numbers.

on the stock market since 2010
3 employees
$1M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $14.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales have been shrinking.

An average decline of 75% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$6.2M
2021
$485K
2022
$339K
2023
$0
2024
$24K
2025
In the vault right now:
$0
DEBT: $11.4M
At this pace, that money lasts about 1.3 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Heavy bets against the stock2/10
Costs eat into the margin4/10
WORTH WATCHING

Bets Against the Stock: The number of investors betting on a fall stands out.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 55% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/1
Sales are holding up

The company sells $24K a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $314K against $24K in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts about 1.3 years. After that, the company needs to find new money.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, EPGNF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: EPGNF is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film